Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 16;8(4):22-31.
doi: 10.15586/jkcvhl.v8i4.182. eCollection 2021.

Genetic Polymorphisms of the TGFB1 Signal Peptide and Promoter Region: Role in Wilms Tumor Susceptibility?

Affiliations

Genetic Polymorphisms of the TGFB1 Signal Peptide and Promoter Region: Role in Wilms Tumor Susceptibility?

Cintya Mayumi Ishibashi et al. J Kidney Cancer VHL. .

Abstract

The aim of the present study was to investigate the rs1800468 (G-800A), rs1800469 (C-509T), rs1800470 (C29T), and rs1800471 (G74C) TGFB1 genetic polymorphisms and their haplotype structures in patients with Wilms Tumor (WT) and neoplasia-free controls. The genomic DNA was extracted from 35 WT patients and 160 neoplasia-free children, and the TGFB1 polymorphisms were genotyped by polymerase chain reaction, followed by restriction fragment length polymorphism. The haplotype structures were inferred, and permutation and logistic regression tests were performed to check for differences in haplotype distribution between the control and WT individuals. Positive associations were found in the recessive model for rs1800469 T allele (OR: 8.417; 95% CI: 3.177 to 22.297; P < 0.001) and for the rs1800470 C allele (OR: 3.000; 95% CI: 1.296 to 6.944; P = 0.01). Haplotype analysis revealed a significant negative association between GCTG and WT (OR: 0.236, 95% CI: 0.105 to 0.534; P = 0.0002); by contrast, the GTTG haplotype was associated with increased risk for WT (OR: 12.0; 95% CI: 4.202 to 34.270; P < 0.001). Furthermore, rs1800469 was negatively correlated with tumor size and a trend toward a positive correlation for capsular invasion was observed in the dominant model (Tau-b: -0.43, P = 0.02 and tau-b: 0.5, P = 0.06, respectively). This is the first study with rs1800468, rs1800469, rs1800470, and rs1800471 TGFB1 polymorphisms in WT, and our results suggest that the TGFB1 promoter and signal peptide region polymorphisms may be associated with WT susceptibility and clinical presentation.

Keywords: TGFB1; Wilms tumor; genetic polymorphism; nephroblastoma; prognosis; susceptibility.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Promoter and signal peptide regions of TGFB1 genetic polymorphisms profile. Electrophoretic profile of: (A) rs1800468 (G-800A), (B) rs1800469 (C-509T), (C) rs1800470 (c.29C>T), and (D) rs1800471 (c.74G>C). The PCR products after restriction digestion were analyzed by electrophoresis on acrylamide gel (10%), detected by silver staining method. L: Ladder 100 bp; C: negative control.

Similar articles

Cited by

References

    1. Rivera MN, Haber DA. Wilms’ tumour: Connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer. 2005;5(9):699–712. 10.1038/nrc1696 - DOI - PubMed
    1. Akpa MM, Iglesias D, Chu L, Thiebaut A, Jentoft I, Hammond L, et al. . Wilms tumor suppressor, WT1, cooperates with microRNA-26a and microRNA-101 to suppress translation of the polycomb protein, EZH2, in mesenchymal stem cells. J Biol Chem. 2016;291(8):3785–95. 10.1074/jbc.M115.678029 - DOI - PMC - PubMed
    1. Royer-Pokora B. Genetics of pediatric renal tumors. Pediatr Nephrol. 2013;28(1):13–23. 10.1007/s00467-012-2146-4 - DOI - PubMed
    1. Cunningham ME, Klug TD, Nuchtern JG, Chintagumpala MM, Venkatramani R, Lubega J, et al. . Global disparities in Wilms tumor. J Surg Res. 2020;247:34–51. 10.1016/j.jss.2019.10.044 - DOI - PubMed
    1. Pritchard-Jones K. Controversies and advances in the management of Wilms’ tumour. Arch Dis Childhood. 2002;87(3):241–4. 10.1136/adc.87.3.241 - DOI - PMC - PubMed

LinkOut - more resources